Newbridge Financial Services Group, Inc. Mei Pharma, Inc. Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	BUY	$0.42 - $0.65 $2,100 - $3,250	5,000 Added 83.33%	11,000 $7,000
Q4 2021 Jan 19, 2022	BUY	$2.33 - $3.37 $2,330 - $3,370	1,000 Added 20.0%	6,000 $16,000
Q2 2021 Sep 07, 2021	BUY	$2.6 - $3.65 $2,600 - $3,650	1,000 Added 25.0%	5,000 $14,000
Q3 2020 Sep 07, 2021	BUY	$2.46 - $4.27 $9,840 - $17,080	4,000 New	4,000 $12,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $370M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.